IRCT2015120910664N2
Completed
未知
Assessment the effect of hydroxychloroquine on the treatment of unexplained recurrent abortion in women referred to Arash hospital
Experimental Medicine Research Centerof Tehran University of Medical Science,Vice chancellor for res0 sites60 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- recurrent abortion.
- Sponsor
- Experimental Medicine Research Centerof Tehran University of Medical Science,Vice chancellor for res
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •inclusion criteria : women with more than 2 unexplained abortion
- •exclusion criteria: women with rheumatoid; lupus erythematosus; underlying and heart diseases; smoking; consumption of alcohol and supplement; radiation contact
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Evaluate the efficacy of hydroxychloroquine in the prevention of SARS-COV2 infection in high risk health care workersIRCT20200414047076N1Esfahan University of Medical Sciences160
Active, not recruiting
Not Applicable
Evaluation of the efficacy of hydroxychloroquine in decreasing immune activation in asymptomatic HIV-infected patients (HCQ-01) - Hydroxychloroquine studyHIV infectionMedDRA version: 9.1Level: LLTClassification code 10020161Term: HIV infectionEUCTR2007-005057-36-GBMedical Research Council
Completed
Not Applicable
HCQ-01 Trial: evaluation of the efficacy of hydroxychloroquine in decreasing immune activation in asymptomatic human immunodeficiency virus (HIV) infected patientsISRCTN30019040Medical Research Council Clinical Trials Unit (MRC CTU) (UK)90
Not yet recruiting
Phase 3
Efficacy of hydroxychloroquine in graves disease in addition to antithyroid drugs.Health Condition 1: E050- Thyrotoxicosis with diffuse goiterCTRI/2023/07/054894IPQA laboratories
Recruiting
Phase 3
Hydroxychloroquine in comparison with hydroxychloroquine + azithromycin in patients with covid-19COVID-19.U07.1 - COVID-19COVID-19IRCT20200428047228N2Quality Improvement of Intensive Care Research Center- Shahid Beheshti University40